These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35122022)

  • 1. Epigenetic Achilles' heel of AML.
    Ueda K; Steidl U
    Nat Cancer; 2021 May; 2(5):481-483. PubMed ID: 35122022
    [No Abstract]   [Full Text] [Related]  

  • 2. Independence of epigenetic and genetic diversity in AML.
    Sasca D; Huntly BJ
    Nat Med; 2016 Jul; 22(7):708-9. PubMed ID: 27387883
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic and epigenetic determinants of AML pathogenesis.
    Cai SF; Levine RL
    Semin Hematol; 2019 Apr; 56(2):84-89. PubMed ID: 30926095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of epigenetic therapy in myelodysplastic syndromes and acute myeloid leukemia.
    Gonzalez-Lugo JD; Chakraborty S; Verma A; Shastri A
    Semin Hematol; 2021 Jan; 58(1):56-65. PubMed ID: 33509444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical developments in epigenetic-directed therapies in acute myeloid leukemia.
    Pan D; Rampal R; Mascarenhas J
    Blood Adv; 2020 Mar; 4(5):970-982. PubMed ID: 32150613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting AML at the intersection of epigenetics and signaling.
    Narayan N; Huntly BJP
    Sci Signal; 2022 Apr; 15(730):eabo0059. PubMed ID: 35439022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epigenetic dysregulation in myelodysplastic syndrome].
    Sashida G; Iwama A
    Rinsho Ketsueki; 2015 Feb; 56(2):111-8. PubMed ID: 25765789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation.
    Tarighat SS; Santhanam R; Frankhouser D; Radomska HS; Lai H; Anghelina M; Wang H; Huang X; Alinari L; Walker A; Caligiuri MA; Croce CM; Li L; Garzon R; Li C; Baiocchi RA; Marcucci G
    Leukemia; 2016 Apr; 30(4):789-99. PubMed ID: 26536822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Clinical Update of Acute Myeloid Leukemia: Focus on Epigenetic Therapies.
    Lee E; Koh Y; Hong J; Eom HS; Yoon SS
    J Korean Med Sci; 2021 Apr; 36(13):e85. PubMed ID: 33821592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy.
    Bret C; Viziteu E; Kassambara A; Moreaux J
    Expert Rev Hematol; 2016; 9(4):351-60. PubMed ID: 26761438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Abnormalities in Acute Myeloid Leukemia and Leukemia Stem Cells.
    Xu J; Hang X; Wu B; Chen C; Liu Y
    Adv Exp Med Biol; 2019; 1143():173-189. PubMed ID: 31338820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic alterations in acute myeloid leukemias.
    Mehdipour P; Santoro F; Minucci S
    FEBS J; 2015 May; 282(9):1786-800. PubMed ID: 25369368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia.
    Wouters BJ; Delwel R
    Blood; 2016 Jan; 127(1):42-52. PubMed ID: 26660432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic modifications in acute myeloid leukemia: The emerging role of circular RNAs (Review).
    Issah MA; Wu D; Zhang F; Zheng W; Liu Y; Fu H; Zhou H; Chen R; Shen J
    Int J Oncol; 2021 Dec; 59(6):. PubMed ID: 34792180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCL2 Inhibition by Venetoclax: Targeting the Achilles' Heel of the Acute Myeloid Leukemia Stem Cell?
    Pullarkat VA; Newman EM
    Cancer Discov; 2016 Oct; 6(10):1082-1083. PubMed ID: 27698099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic changes: a common theme in acute myelogenous leukemogenesis.
    Gutierrez SE; Romero-Oliva FA
    J Hematol Oncol; 2013 Aug; 6():57. PubMed ID: 23938080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic tools in acute myeloid leukemia: From the bench to the bedside.
    White BS; DiPersio JF
    Cancer; 2014 Apr; 120(8):1134-44. PubMed ID: 24474533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia.
    Li Y; Xu Q; Lv N; Wang L; Zhao H; Wang X; Guo J; Chen C; Li Y; Yu L
    J Hematol Oncol; 2017 Feb; 10(1):41. PubMed ID: 28153026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic targeting and personalized approaches for AML.
    Roboz GJ
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):44-51. PubMed ID: 25696833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic modifications in AML and MDS.
    Mahmud M; Stebbing J
    Leuk Res; 2010 Feb; 34(2):139-40. PubMed ID: 19665226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.